209 related articles for article (PubMed ID: 10229296)
1. Effect of aldose reductase inhibitors on glucose-induced changes in sorbitol and myo-inositol metabolism in human neutrophils.
Suzuki K; Kawamura T; Sakakibara F; Sasaki H; Sano T; Sakamoto N; Hotta N
Diabet Med; 1999 Jan; 16(1):67-73. PubMed ID: 10229296
[TBL] [Abstract][Full Text] [Related]
2. Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells.
Sakakibara F; Hotta N; Koh N; Sakamoto N
Diabetes; 1993 Nov; 42(11):1594-600. PubMed ID: 8405700
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
4. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
[TBL] [Abstract][Full Text] [Related]
5. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. I. Restoration of myo-inositol uptake by aldose reductase inhibition.
Cammarata PR; Chen HQ; Yang J; Yorio T
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3561-71. PubMed ID: 1464502
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro.
Kawamura T; Suzuki K; Matsumae H; Sano T; Sakamoto N; Hotta N
Diabet Med; 1995 May; 12(5):392-6. PubMed ID: 7648800
[TBL] [Abstract][Full Text] [Related]
7. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
He J; Gao HX; Yang N; Zhu XD; Sun RB; Xie Y; Zeng CH; Zhang JW; Wang JK; Ding F; Aa JY; Wang GJ
Acta Pharmacol Sin; 2019 Jan; 40(1):86-97. PubMed ID: 29930278
[TBL] [Abstract][Full Text] [Related]
8. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
Cammarata PR; Chen HQ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
[TBL] [Abstract][Full Text] [Related]
9. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells.
Haneda M; Kikkawa R; Arimura T; Ebata K; Togawa M; Maeda S; Sawada T; Horide N; Shigeta Y
Metabolism; 1990 Jan; 39(1):40-5. PubMed ID: 2104641
[TBL] [Abstract][Full Text] [Related]
10. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. II. Characterization of high- and low-affinity myo-inositol transport sites.
Cammarata PR; Chen HQ; Yang J; Yorio T
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3572-80. PubMed ID: 1464503
[TBL] [Abstract][Full Text] [Related]
11. The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells.
Yorek MA; Dunlap JA
Metabolism; 1989 Jan; 38(1):16-22. PubMed ID: 2491899
[TBL] [Abstract][Full Text] [Related]
12. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
13. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
[TBL] [Abstract][Full Text] [Related]
14. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
15. Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucose.
Karihaloo AK; Joshi K; Chopra JS
J Neurochem; 1997 Nov; 69(5):2011-8. PubMed ID: 9349546
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
17. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.
Stevens MJ; Henry DN; Thomas TP; Killen PD; Greene DA
Am J Physiol; 1993 Sep; 265(3 Pt 1):E428-38. PubMed ID: 8214052
[TBL] [Abstract][Full Text] [Related]
19. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
